Opinion: From Polymerase to Politics

Why so few scientists make the leap to policy-making positions, and why more should give it a try

Written byKumar Sukhdeo
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, RCHUON24The intersection of science and technology in our everyday life continues to grow. There is seldom an issue in modern life that does not include some aspect of science, technology, engineering, and mathematics (STEM). These merging entities very often meet, in a practical sense, at the policy level when decisions are made regarding when, where, and how science will affect our society (e.g. genetically-modified foods, climate change, etc.).

Unfortunately, we have witnessed the marginalization of scientific communities in this political dialogue. In contrast to many other governments, trained scientists are underrepresented in the United States Congress; only two US Representatives—Rush Holt (D-NJ) and Bill Foster (D-IL)—hold PhDs in STEM fields. Congressional Science and Technology committees are replete with climate change skeptics. Not surprisingly, federal funding for life science research seems perpetually on the brink of budget cuts or stagnation. It stands to reason that the addition of trained scientists in public office or in more prominent advisory roles would benefit our nation as a leader in STEM fields.

The call for increased involvement is not new, and many researchers continue to advocate for greater involvement of the scientific community in policy decisions. But ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo